BIIB vs MRK
BIIB and MRK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BIIBBIOGEN INC. | MRKMerck & Co., Inc. |
|---|---|---|
| Market cap | $31.89B | $369.89B |
| P/E (TTM) | 23.2 | 119.9 |
| P/B | 2.15 | 8.82 |
| P/S | 3.2x | 5.7x |
| Dividend yield | — | 2.21% |
| Revenue | $9.94B(TTM) | $66.57B(TTM) |
| Revenue growth (YoY) | 2.2% | 1.3% |
| Net income | $1.37B(TTM) | $3.17B(TTM) |
| Earnings growth (YoY) | -20.8% | 6.6% |
| EPS, diluted | $9.30(TTM) | $1.25(TTM) |
| EBIT margin | 28.7% | 34.2% |
| ROE | 8.7% | 43.5% |
| ROIC | 13.0% | 21.6% |
| Piotroski F | 4/9 | — |
| 1y total return | +53.3% | +78.1% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: BIIB vs MRK
| Metric | BIIB | MRK |
|---|---|---|
| End value | $7.9K | $37.4K |
| Total return | -21.4% | +274.4% |
| CAGR | -2.3% | +13.6% |
| Volatility | 41.3% | 23.3% |
| Sharpe | 0.05 | 0.50 |
| Sortino | 0.07 | 0.73 |
| Max drawdown | -72.7% | -43.4% |
Based on 2600 common trading days, 2016-04-29 → 2026-09-01 · risk-free 3.92% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)